Intravenous immunoglobulins for epilepsy
Review was only able to identify one study (n=61) and was thus unable to draw any reliable conclusions regarding the efficacy of IVIg as a treatment for epilepsy. Further randomised controlled trials are needed.
Source:
Cochrane Database of Systematic Reviews